May 1, 2009

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

Key Points

Key points are not available for this paper at this time.

Abstract

At this time, PSA cutoff values (>2.5, 3.0 or 4.0 ng/ml) provide a reasonable balance between excessive detection rates and the risk of missing relevant prostate cancer. Men presenting with PSA values of 2.0-3.0 ng/ml should be reexamined more frequently. Available nomograms applying risk modifiers should be used specifically in this category of men.

Bookmark

Cite This Study

Schröder et al. (Fri,) studied this question.

synapsesocial.com/papers/69d7524aaa68b335b4f30f33 https://doi.org/https://doi.org/10.1097/mou.0b013e328329a2d0

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Early Detection of Prostate Cancer in 20072007 · 175 citations
2Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer1991 · 2,390 citations
3EAU Guidelines on Prostate Cancer2007 · 3,146 citations
4Prostate volume and adverse prostate cancer features: Fact not artifact2007 · 103 citations
5Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)2008 · 51 citations

Bookmark